enVVeno Medical Corporation announced that Andrew Cormack has been hired as the Company's Chief Commercial Officer. Mr. Cormack, who joined enVVeno Medical on April 8, comes to enVVeno following a career at both start-up and large medical device companies including WallabyPhenox, Medtronic, Covidien, and ev3. Mr. Cormack has held numerous regional, national, and international sales and marketing positions throughout his almost 25-year career in med-tech and holds a Bachelor of Arts degree in Kinesiology from The University of Western Ontario, where he graduated with honors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.77 USD | -1.04% | -4.79% | -7.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.20% | 63.58M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- NVNO Stock
- News enVVeno Medical Corporation
- EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer